Page 4 - கிழக்கு கூட்டுறவு புற்றுநோயியல் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Immunotherapy in Patients With Poor Performance Status: The Jury Is Still Out on This Special Population
ascopubs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ascopubs.org Daily Mail and Mail on Sunday newspapers.
EAU 2021: cN+ and Systemic Treatment: Guidelines Point of View More Than ADT is Needed as Systemic TTT: No!
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Expanded Indication for Merck s KEYTRUDA® in Locally Advanced Cutaneous Squamous Cell Carcinoma
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
History
The patient has a medical history of nonalcoholic steatohepatitis with cirrhosis and chronic pancreatitis. She underwent bilateral mastectomy with right axillary lymph node dissection 3 years ago for breast cancer. Pathology returned grade 3 invasive ductal carcinoma measuring 1.8 cm with lymphovascular invasion. Baseline CT scans of the chest, abdomen, and pelvis performed as well as a whole body Tc99m bone scan performed a month postoperatively showed no evidence of metastasis.
Due to the tumor size and presence of lymphovascular invasion, dose-dense doxorubicin and cyclophosphamide (dd AC) followed by weekly paclitaxel was recommended. The patient was counseled on potential adverse reactions before treatment initiation. After therapy was offered and informed consent was obtained, she elected to proceed. Chemotherapy with dd AC every 2 weeks began 1 month postoperatively and concluded after four treatment cycles. The patient was given 6 mg of pegfilgrastim 27 hours after